VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy

The absence of optimal treatments for Diabetic Nephropathy (DN) highlights the importance of the search for novel therapeutic targets. The vascular endothelial growth factor receptor 2 (VEGFR2) pathway is activated in experimental and human DN, but the effects of its blockade in experimental models...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavoz, Carolina, Rodrigues-Diez, Raul R., Plaza, Anita, Carpio, Daniel, Egido, Jesús, Ruiz-Ortega, Marta, Mezzano, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074274/
https://www.ncbi.nlm.nih.gov/pubmed/31973092
http://dx.doi.org/10.3390/jcm9020302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074274/
https://www.ncbi.nlm.nih.gov/pubmed/31973092
http://dx.doi.org/10.3390/jcm9020302

Ejemplares similares